|
Kurt Anker Nielsen (born 1945) is a Danish business executive. He resigned as a director of StatoilHydro (since 2007-10-01) and chairman of the company's audit committee on March 25, 2009, due to the way the Ministry of Petroleum and Energy has handled the issue relating to the company name (). He is a deputy chair of Novozymes〔 (member of the board since 2000)〔(Novozymes Website Profile ), retrieved on 2008-07-09.〕 , a director of Novo Nordisk, ZymoGenetics, Vestas Wind Systems, and Life Cycle. He is also chair of Reliance Industries and Collstrups Mindelegat. Nieslen received an MSc in Economics and Business Administration from Copenhagen Business School, Denmark, in 1972. Nielsen formerly held senior positions with Novo A/S and Novo Nordisk, including senior CFO and managing director.〔''Biography for Kurt Anker Nielsen'', http://www.silobreaker.com, internet posting.〕 He resigned from the board of Novo A/S in August 2006 and was immediately elected to the Board of the Novo Nordisk Foundation.〔(http://novo.dk blurb ), retrieved on 2008-7-10.〕 ==References== 〔 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Kurt Anker Nielsen」の詳細全文を読む スポンサード リンク
|